Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | DDR1 | Q08345 | 17/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL2855263 | 0.84 | ALDH1A1 (0.42) | L3MBTL1DDR1ALDH1A1 | |
| SCHEMBL8244193 | 0.82 | ALDH1A1 (0.49) | DDR1ALDH1A1 | |
| SCHEMBL8253718 | 0.81 | DDR1 (0.50) | DDR1 | |
| SCHEMBL14035945 | 0.80 | ALDH1A1 (0.42) | L3MBTL1ALDH1A1 | |
| SCHEMBL5038734 | 0.78 | ALDH1A1 (0.40) | L3MBTL1DDR1ALDH1A1 | |
| SCHEMBL2535835 | 0.78 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL7366762 | 0.78 | RIPK1 (0.50) | DDR1 | |
| SCHEMBL4598702 | 0.75 | F7 (0.52) | L3MBTL1DDR1 | |
| SCHEMBL5038736 | 0.74 | L3MBTL1 (0.43) | L3MBTL1ALDH1A1 | |
| SCHEMBL2873949 | 0.71 | MAPK1 (0.42) | L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7456195-B2 | Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-11-25 | — | — | US | disclosed |
| US-20070003539-A1 | Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070003539-A1 | Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants | F12, F11, F7 | L3MBTL1 2247/4885DDR1 2051/4885ALDH1A1 2963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.